The 0.3% foam formulation of roflumilast was previously approved for the treatment of seborrheic dermatitis in adults and children aged 9 years and older.

A single-cell analysis of nearly 18,000 white blood cells identifies a unique neutrophil subset characterized by type II ...

Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...

A band of clinicians and chronic pain advocates are pushing regulators to scrutinize a controversial risk rating tool.

Approximately 20% of patients who undergo bronchoscopic lung volume reduction (BLVR) lose the effects of the treatment within ...

Patients with pulmonary embolism (PE) who were treated with mechanical thrombectomy (MT) within 12 hours of hospital ...

Secukinumab use leads to sustained alleviation of pain as well as improvements in quality of life in patients with moderate ...

Varying presentations and different means of measuring frailty make it a slippery target for ICU interventions, experts say ...

GPs can help young people better cope with anxiety by using youth-friendly language, simple techniques, and empowering ...

Children exposed to maternal preeclampsia have a higher risk for kidney disease within a year after birth, regardless of ...

The use of intermittent scanning continuous glucose monitoring improves glycaemic control outcomes in older adult patients ...

Anti-TFAM antibodies are detected in about one third of patients with systemic lupus erythematosus and are associated with a ...